CureVac Financial Statements From 2010 to 2026

5CV Stock  EUR 3.91  0.00  0.00%   
CureVac NV's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing CureVac NV's valuation are provided below:
Gross Profit
66 M
Profit Margin
1.8211
Market Capitalization
885.3 M
Enterprise Value Revenue
7.2313
Revenue
70.7 M
There are over one hundred nineteen available fundamental signals for CureVac NV, which can be analyzed over time and compared to other ratios. Active traders should verify all of CureVac NV prevailing fundamental drivers against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. The current Market Cap is estimated to decrease to about 807.2 M. Enterprise Value is estimated to decrease to about 323.5 M

CureVac NV Total Revenue

646.23 Million

Check CureVac NV financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CureVac NV's main balance sheet or income statement drivers, such as Tax Provision of 34.6 M, Net Interest Income of 14.9 M or Interest Income of 7.3 M, as well as many indicators such as Price To Sales Ratio of 1.51, Dividend Yield of 0.0 or PTB Ratio of 1.16. CureVac financial statements analysis is a perfect complement when working with CureVac NV Valuation or Volatility modules.
  
This module can also supplement various CureVac NV Technical models . Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

CureVac NV Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets845 M923.3 M479.5 M
Slightly volatile
Other Current Liabilities15.7 M16.6 M44.2 M
Pretty Stable
Total Current Liabilities79 M83.2 M86.1 M
Slightly volatile
Other Liabilities198.2 M99.6 M106 M
Slightly volatile
Accounts Payable18.9 M19.9 M23.5 M
Slightly volatile
Cash560.4 M554 M285.4 M
Slightly volatile
Non Current Assets Total208.8 M317.9 M133.9 M
Slightly volatile
Non Currrent Assets Other1.4 M1.7 MM
Slightly volatile
Other Assets4.6 M2.7 M5.3 M
Slightly volatile
Net Receivables12.4 M16.2 M9.5 M
Slightly volatile
Common Stock Shares Outstanding214.3 M258 M191 M
Slightly volatile
Short Term Investments3.1 M3.3 M22.3 M
Slightly volatile
Non Current Liabilities Total29 M30.5 M102.8 M
Very volatile
Inventory591 K622.1 K9.1 M
Slightly volatile
Other Current Assets4.4 MM3.1 M
Slightly volatile
Other Stockholder Equity1.1 BB930.5 M
Slightly volatile
Total Liabilities90.8 M95.6 M186.9 M
Slightly volatile
Deferred Long Term Liabilities258.2 K271.8 K628.9 K
Slightly volatile
Net Invested Capital503 M801.1 M280.1 M
Slightly volatile
Total Current Assets636.3 M605.4 M345.6 M
Slightly volatile
Capital Stock19.3 M31 M10.5 M
Slightly volatile
Non Current Liabilities Other16.2 K17.1 K525.5 K
Slightly volatile
Net Working Capital467.1 M522.2 M254.2 M
Slightly volatile
Intangible Assets13.7 M14.6 M9.7 M
Slightly volatile
Common Stock15.5 M25.8 M10.1 M
Slightly volatile
Property Plant Equipment242 M230.5 M105.9 M
Slightly volatile
Property Plant And Equipment Net208.4 M281.3 M131 M
Slightly volatile
Net Debt27.5 M30.9 M33.7 M
Slightly volatile
Long Term Debt52 M58.5 M63.9 M
Slightly volatile
Property Plant And Equipment Gross249.7 M371.7 M163.1 M
Slightly volatile

CureVac NV Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income7.3 M14.2 M4.9 M
Slightly volatile
Selling General Administrative67.1 M69.9 M43.3 M
Slightly volatile
Total Revenue646.2 M615.5 M129.6 M
Slightly volatile
Other Operating Expenses42.1 M40 M11.4 M
Slightly volatile
Research Development211.5 M176 M121.6 M
Slightly volatile
Cost Of Revenue111.9 M121.7 M64 M
Slightly volatile
Total Operating Expenses295.5 M411.1 M192.5 M
Slightly volatile
Reconciled Depreciation16.2 M21.6 M10.1 M
Slightly volatile

CureVac NV Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow500.3 M462.8 M290.8 M
Slightly volatile
Depreciation15.5 M21.6 M9.8 M
Slightly volatile
Capital Expenditures20.2 M21.2 M27.3 M
Slightly volatile
End Period Cash Flow560.4 M554 M285.4 M
Slightly volatile
Other Cashflows From Investing Activities2.9 M3.7 M2.7 M
Slightly volatile
Stock Based Compensation3.5 M3.7 M14.9 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.511.59400
Slightly volatile
Days Sales Outstanding24.5225.81159
Slightly volatile
Capex To Depreciation1.071.133.4598
Slightly volatile
EV To Sales0.60.64396
Slightly volatile
Inventory Turnover18517637.2394
Slightly volatile
Days Of Inventory On Hand2.042.1571.4039
Very volatile
Payables Turnover5.795.512.8471
Slightly volatile
Sales General And Administrative To Revenue0.140.151.2717
Slightly volatile
Research And Ddevelopement To Revenue0.310.332.7008
Slightly volatile
Capex To Revenue0.03770.03960.9252
Slightly volatile
Cash Per Share2.461.951.6907
Slightly volatile
Days Payables Outstanding65.0868.51168
Slightly volatile
Intangibles To Total Assets0.03430.0360.0402
Slightly volatile
Current Ratio6.886.553.5686
Slightly volatile
Receivables Turnover15.3714.645.9875
Slightly volatile
Graham Number5.696.46.981
Slightly volatile
Capex Per Share0.07030.0740.1667
Slightly volatile
Revenue Per Share2.252.150.533
Slightly volatile
Interest Debt Per Share0.260.20.1254
Slightly volatile
Debt To Assets0.0530.05580.0539
Pretty Stable
Operating Cycle26.5527.95230
Slightly volatile
Days Of Payables Outstanding65.0868.51168
Slightly volatile
Ebt Per Ebit0.810.970.9791
Pretty Stable
Long Term Debt To Capitalization2.342.632.8747
Slightly volatile
Total Debt To Capitalization0.05790.06090.1529
Very volatile
Quick Ratio6.876.543.4689
Slightly volatile
Net Income Per E B T1.080.980.9949
Pretty Stable
Cash Ratio6.295.992.342
Slightly volatile
Days Of Inventory Outstanding2.042.1571.4039
Very volatile
Days Of Sales Outstanding24.5225.81159
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.220.941.1484
Slightly volatile
Fixed Asset Turnover2.071.970.6169
Slightly volatile
Debt Ratio0.0530.05580.0539
Pretty Stable
Price Sales Ratio1.511.59400
Slightly volatile
Asset Turnover0.630.60.1894
Slightly volatile

CureVac NV Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap807.2 M849.7 M6.2 B
Slightly volatile
Enterprise Value323.5 M340.5 M5.9 B
Slightly volatile

CureVac Fundamental Market Drivers

About CureVac NV Financial Statements

CureVac NV stakeholders use historical fundamental indicators, such as CureVac NV's revenue or net income, to determine how well the company is positioned to perform in the future. Although CureVac NV investors may analyze each financial statement separately, they are all interrelated. For example, changes in CureVac NV's assets and liabilities are reflected in the revenues and expenses on CureVac NV's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CureVac NV. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue615.5 M646.2 M
Cost Of Revenue121.7 M111.9 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.15  0.14 
Research And Ddevelopement To Revenue 0.33  0.31 
Capex To Revenue 0.04  0.04 
Revenue Per Share 2.15  2.25 
Ebit Per Revenue 0.30  0.31 

Currently Active Assets on Macroaxis

When determining whether CureVac NV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CureVac NV's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Curevac Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Curevac Nv Stock:
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Understanding that CureVac NV's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether CureVac NV represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, CureVac NV's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.